Stoke Therapeutics (STOK) Other Non-Current Assets (2018 - 2026)
Stoke Therapeutics (STOK) posted Other Assets of $3.23 million for Q3 2026, up 347.6% from $721,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Stoke Therapeutics (STOK) Other Non-Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, Stoke Therapeutics' Other Assets came in at $227,000, down 68.5% from FY2024.
- Annual Other Assets shows a five-year compound annual growth rate of 2.1% (FY2020 to FY2025).
- In prior years, Stoke Therapeutics' Other Assets was $721,000 in FY2024 (+26.7%), $569,000 in FY2023 (unchanged), $569,000 in FY2022 (unchanged) and $569,000 in FY2021 (+177.6%).
- On a year-over-year basis, Other Assets has increased in each of the last three quarters, with growth averaging 139.9% over the last eight quarters.
- The strongest year-over-year quarter for Other Assets in the past five years was Q1 2022, with growth of 881.0%; the weakest was Q4 2025, with a decline of 68.5%.
- According to Business Quant data, Other Assets for the three prior quarters was $3.23 million (Q2 2026), $3.23 million (Q1 2026) and $227,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Stoke Therapeutics | 1.90 Bn | 658.22 Mn | - | 3.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.23 Mn |
| Jun 30, 2026 | 3.23 Mn |
| Mar 31, 2026 | 3.23 Mn |
| Dec 31, 2025 | 227,000.00 |
| Sep 30, 2025 | 721,000.00 |
| Jun 30, 2025 | 721,000.00 |
| Mar 31, 2025 | 721,000.00 |
| Dec 31, 2024 | 721,000.00 |
| Sep 30, 2024 | 494,000.00 |
| Jun 30, 2024 | 494,000.00 |
| Mar 31, 2024 | 569,000.00 |
| Dec 31, 2023 | 569,000.00 |
| Sep 30, 2023 | 569,000.00 |
| Jun 30, 2023 | 569,000.00 |
| Mar 31, 2023 | 569,000.00 |
| Dec 31, 2022 | 569,000.00 |
| Sep 30, 2022 | 569,000.00 |
| Jun 30, 2022 | 569,000.00 |
| Mar 31, 2022 | 569,000.00 |
| Dec 31, 2021 | 569,000.00 |
API Access
Stoke Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=STOK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "STOK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=STOK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();